News
Korea GSK marks 40 years, boosts patient-centered innovation and R&D
10+ hour, 28+ min ago (13+ words) CHOSUNBIZ Chosunbiz...
Astra Zeneca heart drug misses phase 3 goal as design woes sink shares
19+ hour, 8+ min ago (403+ words) Trial stumble dents credibility but rivals gain as monotherapy signal offers limited solace UK drugmaker Astra Zeneca has suffered a major setback in a pivotal phase 3 trial to expand the indication for its rare heart disease treatment "Wainua." The market…...
LKB Pyeongsan sues Gyodong F&B over mass food poisoning in South Korea
14+ hour, 34+ min ago (197+ words) LKB Pyeongsan Law Firm said on the 6th that it filed a class-action lawsuit (claim for damages) on behalf of victims of the Gyodongmyeonok mass food poisoning case against Gyodong F&B Co. , the headquarters of Gyodongmyeonok. According to LKB Pyeongsan,…...
Choo Sa-rang confronts mother Yano Shiho over puberty stress
20+ hour, 58+ min ago (11+ words) Chosunbiz...
Hanmi advances belvarafenib phase 2 in South Korea, targets 2028 approval
16+ hour, 35+ min ago (393+ words) Phase 2 combo trial with cobimetinib advances in Korea, aiming for conditional approval by 2028 Hanmi Pharmaceutical(128940) said on the 10th that phase 2 of a domestic clinical trial of the oral targeted anticancer drug "Belvarafenib," which targets NRAS gene mutation melanoma with no…...
Korea warns against cosmetic misuse of Wegovy and Mounjaro after mixed results
17+ hour, 5+ min ago (292+ words) We examine the misuse and side effects hidden behind the severe shortages of the weight-loss injections Wegovy and Mounjaro that have shaken the world. In the SBS News Story airing at 8 a. m. on the 11th, the program looks into the light and…...
HLB group stocks sink in South Korea after FDA rejects liver cancer drug
18+ hour, 50+ min ago (15+ words) CHOSUNBIZ Chosunbiz...
GC Biopharma partners with Koreavaccine to expand Korea flu shot production
19+ hour, 9+ min ago (13+ words) CHOSUNBIZ Chosunbiz...
Gencraft revives RUNX3 to trigger cancer cell suicide in South Korea trial
21+ hour, 45+ min ago (986+ words) SNU-backed startup tests intratumoral AAV gene therapy to restore RUNX3 and tackle KRAS-driven resistance Lung cancer, the No. 1 cause of cancer deaths worldwide. Among them, the "KRAS mutation," which accounts for about 30% of all genetic alterations, has long been called an…...
Oscotec launches Korea phase 1 for resistance-targeting cancer drug, boosts R&D
1+ day, 18+ hour ago (15+ words) Oscotec starts Korea phase 1 for anti-resistance cancer drug, targets 2030 deals - CHOSUNBIZ Chosunbiz...